Bitter Pill, page-72

Full disclosure, I sold yesterday after holding for 5+ years because I felt as though mesoblast was now a 50/50 gamble with only CLBP results left to bump the share price, however after listening to the webcast, it is still very promising how much of an effect their stem cells have on patients who are exhibiting severely dysregulated immune responses. I honestly think Hearst failure will be a great success and maybe ards too. I think for me, I was expecting things to have solid answers by the end of this year but unfortunately it looks as though there is a fair bit more work left to do yet which is why I have sold my position for a slight profit. I look forward to jumping back in when things are looking a bit more promising and a bit less of a gamble. Gltah